NewLimit Raises $130 Million for AI-Driven Longevity Research
- NewLimit, co-founded by Coinbase CEO Brian Armstrong, raised $130 million in Series B funding.
- Total funding for NewLimit now exceeds $170 million.
- The round was led by Kleiner Perkins with participation from Founders Fund and Dimension Capital.
- New investors include former GitHub CEO Nat Friedman and Khosla Ventures.
- The company focuses on increasing healthy lifespan through AI-driven cell reprogramming.
Biotechnology startup NewLimit has secured $130 million in a Series B funding round, bringing its total funding to over $170 million. The company aims to extend healthy life expectancy using AI and genomics.
Source (2.6)https://decrypt.co/318262/coinbase-ceos-biotech-firm-gets-130m-to-fight-aging-with-ai-genomics?rand=52368
